Literature DB >> 22977403

Vasopressin as first-line therapy for cardiac arrest: a review of the guidelines and clinical-effectiveness.

.   

Abstract

Entities:  

Year:  2010        PMID： 22977403      PMCID： PMC3411147     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  18 in total

Review 1.  European Resuscitation Council guidelines for resuscitation 2005. Section 4. Adult advanced life support.

Authors:  Jerry P Nolan; Charles D Deakin; Jasmeet Soar; Bernd W Böttiger; Gary Smith
Journal:  Resuscitation       Date:  2005-12       Impact factor: 5.262

2.  2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors: 
Journal:  Circulation       Date:  2005-11-28       Impact factor: 29.690

3.  ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-25       Impact factor: 29.690

Review 4.  Evolving role of vasopressin in the treatment of cardiac arrest.

Authors:  Todd A Miano; Michael A Crouch
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

Review 5.  Vasopressin for cardiac arrest: a systematic review and meta-analysis.

Authors:  Koko Aung; Thwe Htay
Journal:  Arch Intern Med       Date:  2005-01-10

6.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

Review 7.  Cardiac arrest care and emergency medical services in Canada.

Authors:  Christian Vaillancourt; Ian G Stiell
Journal:  Can J Cardiol       Date:  2004-09       Impact factor: 5.223

8.  A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.

Authors:  Volker Wenzel; Anette C Krismer; H Richard Arntz; Helmut Sitter; Karl H Stadlbauer; Karl H Lindner
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

9.  Effects of epinephrine and vasopressin on end-tidal carbon dioxide tension and mean arterial blood pressure in out-of-hospital cardiopulmonary resuscitation: an observational study.

Authors:  Stefan Mally; Alina Jelatancev; Stefek Grmec
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  Vasopressin combined with epinephrine during cardiac resuscitation: a solution for the future?

Authors:  Volker Wenzel; Karl H Lindner
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.